BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 8083461)

  • 1. Rush Hymenoptera venom immunotherapy: successful treatment in a patient with systemic mast cell disease.
    Engler RJ; Davis WS
    J Allergy Clin Immunol; 1994 Sep; 94(3 Pt 1):556-9. PubMed ID: 8083461
    [No Abstract]   [Full Text] [Related]  

  • 2. Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in ten patients.
    Fricker M; Helbling A; Schwartz L; Müller U
    J Allergy Clin Immunol; 1997 Jul; 100(1):11-5. PubMed ID: 9257781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rush hymenoptera venom immunotherapy is efficacious and safe.
    Pasaoglu G; Sin BA; Misirligil Z
    J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hymenoptera venom immunotherapy: Past, present, and future.
    Oppenheimer J; Golden DBK
    Ann Allergy Asthma Immunol; 2018 Sep; 121(3):276-277. PubMed ID: 29909053
    [No Abstract]   [Full Text] [Related]  

  • 5. Ultrarush immunotherapy in patients with Hymenoptera venom allergy.
    Ruëff F; Przybilla B
    J Allergy Clin Immunol; 2001 May; 107(5):928-9. PubMed ID: 11344369
    [No Abstract]   [Full Text] [Related]  

  • 6. Anaphylactoid shock following Hymenoptera sting as a presenting symptom of systemic mastocytosis.
    Kors JW; van Doormaal JJ; de Monchy JG
    J Intern Med; 1993 Mar; 233(3):255-8. PubMed ID: 8450293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunotherapy against hymenoptera venom: report of ten patients].
    Guzmán M MA; Salinas L J; Toche P P; Marinovic M MA; Gallardo O AM
    Rev Med Chil; 2007 Dec; 135(12):1566-71. PubMed ID: 18357358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venom immunotherapy: tolerance to a 3-day protocol of rush-immunotherapy.
    Díez Gómez ML; Quirce Gancedo S; Juliá de Páramo B
    Allergol Immunopathol (Madr); 1995; 23(6):277-84. PubMed ID: 8579006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse reactions to venom immunotherapy.
    Ramirez DA; Londono S; Evans R
    Ann Allergy; 1981 Dec; 47(6):435-9. PubMed ID: 7325415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring of specific immunotherapy with 3M Fluoro-FAST in insect sting sensitive patients.
    Szymański W; Kazberuk M; Chyrek-Borowska S
    Pneumonol Alergol Pol; 1992; 60 Suppl 1():63-6. PubMed ID: 1292850
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety profile of hymenoptera venom immunotherapy (VIT) in monosensitized patients: lack of new sensitization to nontreated insect venom.
    Spoerl D; Bircher AJ; Scherer K
    J Investig Allergol Clin Immunol; 2011; 21(1):22-7. PubMed ID: 21370719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of specific IgE and IgG4 measurements in the follow-up of a hymenoptera venom immunotherapy treatment: apropos of 82 cases].
    Sonneville A; Loustanau O; Tahar HA; Menelet I
    Allerg Immunol (Paris); 2000 Jan; 32(1):20-5. PubMed ID: 10723532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rush Hymenoptera venom immunotherapy: a safe and practical protocol for high-risk patients.
    Sturm G; Kränke B; Rudolph C; Aberer W
    J Allergy Clin Immunol; 2002 Dec; 110(6):928-33. PubMed ID: 12464961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Case Study in Health Disparities: Barriers to Immunotherapy for Venom-Induced Anaphylaxis.
    Satyavarapu I; Hein N; Carlson JC
    J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2568-2569. PubMed ID: 37301432
    [No Abstract]   [Full Text] [Related]  

  • 15. [When can desensitization with bee and wasp venom be stopped?].
    Oei HD; Stroes ES; Beukema WP; van der Zwan JC
    Ned Tijdschr Geneeskd; 1991 Apr; 135(16):719-20. PubMed ID: 2038399
    [No Abstract]   [Full Text] [Related]  

  • 16. Continuous immunotherapy for hymenoptera venom allergy using six month intervals.
    Baenkler HW; Meusser-Storm S; Eger G
    Allergol Immunopathol (Madr); 2005; 33(1):7-14. PubMed ID: 15777517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sting challenge test in Hymenoptera venom allergy: pros and cons.
    Bilò MB; Brianzoni MF; Garritani MS; Antonicelli L; Farabollini B; Bonifazi F
    Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):377-81. PubMed ID: 14768522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Desensitization of allergy to hymenoptera venoms].
    Przybilla B; Ruëff F
    Wien Med Wochenschr; 1999; 149(14-15):421-8. PubMed ID: 10584286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venom extracts available to treat patients at risk from insect stings.
    Gunby P
    JAMA; 1979 May; 241(21):2243-6. PubMed ID: 439282
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical and immunological studies of venom immunotherapy.
    Reisman RE; Arbesman CE; Lazell M
    Clin Allergy; 1979 Mar; 9(2):167-74. PubMed ID: 445786
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.